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I
n all cell types of the body, save one, the insulin gene
is quiescent and is ensconced in a compact and
protected environment of chromatin. How the insu-
lin gene is coaxed out of its chromatin slumber in
the pancreatic -cell is unknown. Moreover, this question
is of practical concern to current efforts to transform
stems cells or other cells types to become insulin-secreting
cells as means for treating type 1 diabetes. The DNA of all
eukaryotic organisms including humans is wrapped
around an octamer of the histone proteins H2A, H2B, H3,
and H4 and garnished with a large array of proteins that
collectively orchestrate the higher-order packaging, DNA
replication, chromosomal division and recombination, and
gene transcription. In recent years, molecular biologists
have discovered that an essential step of teasing a gene out
of dormancy is to modify the histones that lie in direct
contact with the regulatory regions of genes. The two most
important enzymatic histone modiﬁcations in this process
are acetylation and methylation (1–3), which act together
to open the chromatin structure and allow access of the
promoter regions of genes to RNA polymerase and other
transcription factors. Methylation of a speciﬁc lysine res-
idue (Lys4) in the H3 histone (H3K4) is the most common
modiﬁcation in the gene promoter region of “poised” or
actively transcribing genes (4,5). The methylation of H3K4
can vary between one to three methyl groups being added
to this single lysine residue.
Mirmira and coworkers (6,7) had previously shown that
the insulin promoter exhibited a high degree of H3K4
dimethylation in -cells but not in other cell types. More-
over, H3K4 methylation of the insulin promoter is largely
dependent upon the recruitment of the Set7/9 methyltrans-
ferase to the promoter in the presence of the pancreatic
duodenal homeobox-1 (PDX-1, a.k.a. insulin promoter
factor-1 [IPF-1]), an all important transcription factor that
is required to specify and maintain -cell development as
well as promote insulin gene transcription (8).
The functional importance of H3K4 dimethylation of the
insulin promoter was not previously explicitly addressed.
In the current issue of Diabetes, Deering et al. (9) reveal
the role of the Set7/9 methyltransferase in regulating the
transcription of the insulin gene as well as other important
-cell genes. As a prelude to the functional studies, they
found that Set7/9 is highly expressed in the islet - and
-cells and is likely to owe its high expression to transcrip-
tional activation mediated by PDX-1. To assess the func-
tional importance of Set7/9, the Set7/9 protein was
depleted in the -cell line TC3 using siRNA transfection.
Three genes—Ins1/2, Mafa, and Glut2 (Slc2a2)—were
consistently downregulated when Set7/9 was depleted,
whereas several other important -cell genes (e.g., Nkx6.1,
the sulfonylurea receptor, a subunit of the ATP-sensitive
K
 channel, glucokinase, and Pdx1) were unaffected.
Reduction of Ins1/2 and Glut2 mRNAs was also found to
be associated with reduced H3K4 dimethylation in the
promoter region of these two genes.
To conﬁrm the relevance of these ﬁndings, Deering et al.
depleted Set7/9 by directly injecting chemically stabilized
siRNA into mice. Although this unusual strategy does not
result in exclusive targeting of siRNA to the -cells, it can
be effective when the targeted gene is highly expressed in
the tissue under study and the tissue is particularly com-
petent for siRNA transfection —and in this case it worked.
Ins1/2, Mafa, and Glut2 were again downregulated in the
islets of the injected mice by two independent siRNAs
directed against Set7/9. Moreover, the physiology of the
islets was altered as shown by a decrease in glucose-
stimulated calcium mobilization and insulin secretion.
What speciﬁc role does Set7/9 and H3K4 dimethylation
play in transcription of the insulin gene in the context of
other transcription factors? PDX-1 appears to be required
at the insulin promoter to transition the RNA polymerase
from transcription initiation to elongation but is insufﬁ-
cient by itself to recruit RNA polymerase to the promoter
(Fig. 1). Deering et al. show that depleting Set7/9 results
in decreased recruitment of RNA polymerase II to the
insulin and glut2 promoter. PDX-1 is required for Set7/9
to bind to these promoters, whereas PDX-1 can bind
them without Set7/9. Not addressed is whether Set7/9
only acts to methylate H3K4 or is also required to be
bound at the promoter to maintain the methylated state,
i.e., does the prince kiss and run or hang around for a
stable relationship?
Future studies are needed to determine whether H3K4
dimethylation by Set7/9 is required to establish an active
insulin promoter during the initial differentiation of the
endocrine progenitor cells into -cells during embryonic
development. Once the differentiated state is established,
it must be maintained during cell division when many
tissue-speciﬁc expressed genes are transiently turned off
(2,5). The epigenetic memory of transcriptionally active
genes during mitosis appears to involve a complex set of
modiﬁcations comprised of methylation and acetylation of
both histones and DNA. The establishment and regulation
of chromatin interactions at the insulin gene as well as key
regulators of -cell development are pertinent to ongoing
efforts to develop surrogate sources of insulin in the
treatment of type 1 diabetes. Recently Zhou et al. (10)
demonstrated that exocrine pancreatic acinar cells could
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by injecting three genes (Pdx1, Ngn3, and Mafa) into adult
pancreata of mice. Although chromatin modiﬁcation was
not investigated in this latter study, we can surmise that
Set7/9 may have been activated in these cells by virtue of
the increased levels of PDX-1. Introduction of these three
genes in other tissues did not result in reprogramming,
suggesting that the exocrine pancreas, which shares a
common developmental origin with the endocrine pan-
creas, is predisposed to reprogramming to -cells. This
predisposition of exocrine pancreatic acinar cells may be
related to epigenetic memory of chromatin from early
stages of pancreatic development before the separation of
endocrine and exocrine pancreatic lineages. Changes in
the H3 methylation status are also correlated with gene
silencing, and Park et al. (11) have shown that type 2
diabetes induced by intrauterine growth retardation is
associated with silencing of Pdx1 through demethylation
of H3K4 and methylation of H3K9. Further research is
clearly warranted to conﬁrm the cause-and-effect relation-
ship of chromatin modiﬁcation and regulation of gene
expression in -cells and to extend these studies to
humans as related to both the etiology and treatment of
diabetes.
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FIG. 1. Proposed model for activation of transcription of the insulin
gene mediated by H3K4 methylation. PDX-1 is proposed to bind ﬁrst to
the insulin promoter, allowing the recruitment of Set7/9 followed by
dimethylation of H3K4. Methylation H3K4 opens the chromatin struc-
ture of the promoter and facilitates recruitment of RNA polymerase II
and subsequent transcription of the insulin gene. Numerous other
transcription factors and modifying enzymes participate in these reac-
tions (not shown), but their interactions with Set7/9 and PDX-1 are
largely unknown.
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